Long-term safety of darolutamide in patients with metastatic castration-resistant prostate cancer

Egils Vjaters, Karim Fizazi, Nicholas D. James, Teuvo Tammela, Nobuaki Matsubara, Frank Priou, Thierry Lesimple, Petri Bono, Vesa V. Kataja, Jorge A. Garcia, Andrew Protheroe, John Aspegren, Heikki Joensuu, Iris Kuss, Silke Thiele, Sabine Fiala-Buskies, Robert Hugh Jones

Research output: Contribution to journalMeeting Abstractpeer-review

Fingerprint

Dive into the research topics of 'Long-term safety of darolutamide in patients with metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science